Please sign in to follow a disease.
Can a smartphone and a doula help pregnant women battling addiction?
NCT ID NCT07642947
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study aims to see if a program that combines peer doula support with digital tools (like smartphones) is practical and well-liked by patients and staff at two clinics. About 100 participants, including healthcare workers and pregnant or postpartum people with substance use disorders, will complete surveys and interviews. The goal is to gather feedback and explore whether the program helps with treatment and prenatal care attendance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Feb 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Staff participants and patient participants will be selected from two participating clinical sites that have implemented the digitally enhanced peer doula model of care.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Staff Participant Inclusion Criteria: 1. 18 years of age or older. 2. Employed by the participating clinic site and identified as care providers and/or administrative staff. Clinic roles may include: 1. Provider (including MD, CNM, DO, PA, NP, nurse, medical assistant, behavioral health clinician, social worker, lactation consultant and/or other clinical roles that provide care to patients). 2. Peer doulas. 3. Administrator (including front desk staff, scheduler, clinic and/or team manager). 4. Site leadership. 3. Able to speak English sufficiently to understand the study and, having understood, provide written informed consent to participate in the study. Exclusion Criteria: 1. Unwilling or unable to provide consent 2. Currently detained in jail, prison, residential substance use treatment facility, or other overnight facility as required by court of law; or have pending legal action that could prevent participating in study activities Patient Participant (Cohort 1 \& Cohort 2) Inclusion Criteria 1. 18 years of age or older 2. Patient of the participating site who is eligible to receive prenatal, postpartum, or delivery services •Either 1. Not currently engaged in the digitally enhanced peer doula model and no prior exposure to the model or less than 30 days exposure to the model if newly enrolled, AND currently pregnant or up to 6 weeks postpartum. OR 2. Currently engaged in the digitally enhanced peer doula model for more than 30 days, AND currently pregnant or up to one year postpartum 3. Able to speak English sufficiently to understand the study and, having understood, provide written informed consent to participate in the study. Exclusion Criteria: 1. Unable or unwilling to provide consent to participate in study activities 2. Currently detained in jail, prison, residential substance use treatment facility, or other overnight facility as required by court of law; or have pending legal action that could prevent participating in study activities 3. Currently unable to engage in the digitally enhanced peer doula model or attend research visits
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Perinatal substance use are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, 03766, United States
-
The OHSU MEADOWLARK Program (MEntal health and ADdiction integrated for Obstetric Wellness)
Portland, Oregon, 97239, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.